Top Australian Dermatologist: Use This For 60 Seconds On Your Hair And See What Happens To Your Alopecia

Patchy. Slow. Comes in thin — then sheds again.

You've suppressed the immune attack.

You've done the injections, the topical steroids, maybe even the JAK inhibitor cycle.

And regrowth still isn't performing the way it should.

You're not imagining it. And you're not being impatient.

There is a specific reason your follicles aren't coming back — and it has nothing to do with your primary treatment working or not working.

Let me explain exactly what it is.

Did You Know There's a Process Happening at Your Follicle That Even Your Dermatologist Hasn't Talked to You About?

It's called perifollicular fibrosis.

And if you've been managing alopecia for more than six months, it's almost certainly already happening to you.

Here's what it is:

When hair loss sets in — whether the cause is androgenetic, diffuse, or autoimmune like alopecia areata — the connective tissue sheath surrounding each follicle begins to change.

It hardens.

The tissue that was soft and open, allowing blood, oxygen, and nutrients to flow freely into the follicle, begins to tighten. To stiffen. To calcify around the follicle structure.

This is called perifollicular fibrosis — and it progresses independently of whatever is triggering your hair loss in the first place.

Which means it progresses whether you're in active treatment or not.

Under normal conditions, a follicle that has entered the resting phase can return to active growth.

That's what regrowth is. That's what treatment is supposed to enable.

But when perifollicular fibrosis develops around that dormant follicle?

The structural environment it needs to come back is gone.

Think of it like this:

A plant that was deprived of water goes dormant — but it doesn't die. Put water back and it will grow.

Unless the soil around the roots has hardened into concrete.

Then it doesn't matter how much water you pour on it. The root can't access what it needs.

That's what perifollicular fibrosis does to your follicles.

This Is the Process That Gets Worse With Every Month It Goes Unaddressed

At first, you might see partial regrowth — new hair coming in finer than pre-loss, or filling in unevenly across a patch.

Then you might notice the regrowth is slower than expected between treatment cycles.

Then certain patches stop responding at all.

The autoimmune attack might be suppressed. Your bloodwork might look fine.

But the structural environment at the follicle has been progressively deteriorating — and no treatment you've been prescribed was ever designed to address it.

Because:

Corticosteroid injections suppress immune activity. They reduce the inflammatory response attacking the follicle. But they do not address the connective tissue hardening around it.

JAK inhibitors block the JAK-STAT signalling pathway driving the autoimmune attack. Remarkable technology. Genuinely life-changing for many women. But they were not designed — and do not function — as anti-fibrotic agents.

Minoxidil widens blood vessels and temporarily increases scalp circulation. But increased blood flow reaching a follicle surrounded by hardened tissue cannot penetrate the barrier that fibrosis has created.

Biotin supplements, keratin treatments, and every oral hair vitamin work on the hair shaft, not the follicle structure. They feed hair you still have. They cannot reach the root environment that determines whether dormant follicles come back.

None of them target the fibrotic hardening.

And that hardening keeps working.

Every month.

Every missed regrowth cycle.

Every patch that came back thin and then shed again.

Here's the Bad News

The bad news is that perifollicular fibrosis doesn't stop on its own.

Unlike acute inflammation that responds to treatment, the structural hardening around follicles is progressive. It develops incrementally. And the longer it develops unchecked, the more it limits what recovery is possible.

This is the clinical reason why women who start addressing the follicle environment early see significantly better regrowth outcomes than women who wait.

It is also the reason many women on primary treatment — who are doing everything right — are still not getting the regrowth results they expected.

And here's what makes it worse:

Most solutions that exist for alopecia are aimed at the wrong target.

You've probably tried some of these:

Corticosteroid injections— the most common first-line treatment. Dozens of needle insertions per session. Painful. Expensive at $500–$1,500 per session. Effective at suppressing the immune attack. Does not touch perifollicular fibrosis. The moment injections stop, autoimmune activity frequently resumes. And the fibrosis that developed during treatment continues regardless.

Topical immunotherapy (DPCP)— irritant contact dermatitis applied weekly or fortnightly. Genuinely effective for some women. Addresses immune activation. Does not address follicle structural deterioration. And monthly clinic visits become an indefinite commitment.

JAK inhibitors (Baricitinib, Ritlecitinib)— the most significant advance in alopecia areata treatment in decades. But they require ongoing use, carry systemic side effects, and when treatment stops, relapse rates are high. They were never designed to address perifollicular fibrosis.

Minoxidil— studied for alopecia areata as an adjunct. Does not suppress the autoimmune mechanism. Does not inhibit fibrosis. Comes with scalp irritation, an initial shedding phase, and the widely-reported unwanted facial hair side effect. Stop using it and anything it stimulated regresses within weeks.

Platelet-Rich Plasma (PRP) injections— growth factors injected into the scalp. $1,500–$2,500 per session. Results last 3–6 months before another round is needed. Does not address the autoimmune mechanism. Does not address perifollicular fibrosis. 40% of patients see no meaningful improvement.

None of these solutions address perifollicular fibrosis.

Because until very recently, almost nothing did.

So What Actually Addresses It?

You need to inhibit the collagen cross-linking process that drives the fibrosis — at the follicle level, at a meaningful concentration — so the structural environment around dormant follicles can remain open and accessible.

But there's a critical delivery requirement:

The active has to physically reach the follicle.

Oral supplements can't guarantee this. Shampoos sit on the shaft. Clinical machines deliver it in clinic at a price most women can't sustain.

The active itself is called Aminexil.

Aminexil was developed by L'Oréal Professionnel's clinical research division.

Its mechanism is specific: it inhibits the cross-linking of perifollicular collagen — the precise molecular process that causes tissue to harden around the follicle. By blocking this process, Aminexil keeps the connective tissue sheath surrounding each follicle soft, open, and structurally capable of sustaining the return to the growth phase.

Clinical assessment with Aminexil showed measurably fuller, stronger hair in six weeks.

Not six months. Six weeks.

Not by forcing new follicles. Not by masking thinning. By removing the structural barrier that was preventing existing dormant follicles from coming back.

Why haven't you heard of it?

Because the companies that fund most hair loss education — the supplement brands, the PRP clinic chains, the Minoxidil manufacturers — have no commercial interest in spreading information about an active that competes with their products.

And because without that funding, most dermatologists and trichologists never encounter it in continuing professional education.

There is only one problem...

The Technology Existed. The Access Didn't.

Aminexil has been used in L'Oréal Professionnel's clinical haircare range for years.

But clinical-grade Aminexil, delivered at a therapeutically meaningful concentration, was only available through professional salon treatments — $300–$600 per session — or clinic-grade formulations that required specialist appointments most women couldn't justify.

The research was there.

The mechanism was there.

But it was locked behind a price point and an access model that kept it out of reach for the overwhelming majority of women who needed it.

So I partnered with an Australian-based botanical laboratory that has helped more than 12,000 Australian women address hormonally-driven and follicle-level hair loss.

And together, we've made this anti-fibrotic technology accessible — and combined it with two additional actives that address the hormonal and growth-cycle environment at the scalp simultaneously.

Introducing HaloGrow™: The Follicle Rescue Spray That Addresses What Your Treatment Missed

HaloGrow™ is the only topical spray available in Australia that delivers Aminexil's anti-fibrotic mechanism alongside a dual-pathway growth-phase support stack — in one 60-second daily spray, from your own bathroom.

It may look like a simple pump bottle.

But when you part your hair and spray HaloGrow™ directly onto your scalp — and massage it into the areas where regrowth has been slow, thin, or absent...

Something different starts happening.

Not because it's suppressing your immune system. Not because it's pumping more blood flow to the surface.

Because it's addressing the structural environment at the follicle that determines whether dormant follicles can physically return to the growth phase.

And because it pairs that with two additional actives that no other spray in this category combines at clinically meaningful doses.

THE THREE-PART MECHANISM:

HaloGrow™ doesn't replace your primary treatment.

It addresses the layer your primary treatment was never designed to reach.

And it's pre-formulated with all three actives at clinically meaningful concentrations — not at trace amounts included to satisfy a label requirement.

But don't take my word for it.

At the time of writing this, over 8,400 Australian women have used HaloGrow™.

It has more than 4,300 five-star reviews.

Here is what women managing alopecia have said:

Now, I know you have two questions.

How do you get HaloGrow™ — and what does it cost?

Well, the first question is more complicated than it sounds.

HaloGrow™ is not a mass-produced salon product.

Every ingredient is sourced to pharmaceutical-grade specification. The Aminexil concentration is calibrated precisely — too low and it doesn't reach the follicle in a meaningful concentration; at the right level it's the most effective anti-fibrotic topical available without a prescription.

That means our production batches are limited. And demand from women who've found this through alopecia support groups and clinical referrals has been relentless.

We've sold out three times in the last four months.

The most recent restock — 8,000 units — has been moving faster than any previous batch.

Our laboratory produces a fixed number of bottles per week. Getting another batch manufactured, quality-tested, and shipped takes anywhere from two to six weeks.

If you can see this page, stock is currently available.

We take the page down when we're out.

But I cannot tell you for how much longer.

We Could Sell Out Today. Or This Week. We Can't Predict It Anymore.

Once we're out, it's 2–6 weeks for the next batch.

And the price goes back up when it returns.

If you're serious about supporting your follicle environment — and giving your primary treatment the structural conditions it needs to work — do not close this page.

HaloGrow™ is not available through Chemist Warehouse, pharmacies, or any third-party retailer. If you see something that looks similar elsewhere, it is not formulated with the clinically studied Aminexil concentration that makes HaloGrow™ work. The only authentic HaloGrow™ is purchased directly through our official website.

Now, let's talk about price.

The clinical-grade treatments that target perifollicular fibrosis in dermatology settings cost hundreds per session — and require ongoing sessions. PRP runs $1,500–$2,500. JAK inhibitor prescriptions in Australia cost $1,000+ annually for private patients. Corticosteroid injection sessions cost $500–$1,500.

Our clinical and business advisors told us we should price HaloGrow™ at $89 per bottle.

Given the concentration of actives, the clinical research behind each ingredient, and the results it's delivering — that would have been fair.

But I'm not a businesswoman. I'm a dermatologist.

And I've spent fifteen years watching women with alopecia spend enormous amounts of money on treatments that left the structural follicle problem entirely unaddressed.

I wanted every woman in an alopecia support group — every woman who's spent thousands on injections and still isn't seeing the regrowth she expected — to be able to access this.

We Priced It at a Fraction of What Our Advisors Recommended

Just $89 per bottle.

Even at that price, it's less than a single PRP session. Less than two months of JAK inhibitor prescriptions at private rates. Less than four corticosteroid injection sessions per year.

For the only spray that addresses the structural follicle environment your primary treatment was never designed to reach.

And unlike clinic-based treatments, you use it at home. 60 seconds every morning. No appointments. No waiting rooms. No gaps in your protocol because you couldn't get in.

But I wasn't done.

Because the women who need this most are often the ones who've already spent the most.

I know what it's like to have an alopecia cabinet — supplements, serums, salon treatments, clinic receipts — and still not have your hair.

So I made a decision.

I'm Offering a Special Limited-Time Discount — 70% OFF

That's just $26.70 per bottle on the 3-month supply.

Less than a week's coffee.

Less than the copay on your last dermatologist visit.

For the ingredient stack that addresses the part of your alopecia progression nobody else has targeted.

I can only guarantee this price while the current stock holds.

This is the lowest price HaloGrow™ has ever been offered at.

And I cannot promise it will still be here tonight.

Click below to claim your bottles before stock runs out.

You Have 30 Days to Test It With Essentially Zero Risk

I mean that.

30 full days to use HaloGrow™ alongside whatever you're currently doing for your alopecia.

Spray it onto your scalp every morning. 60 seconds.

Watch your shower drain. Count the shed hairs. Photograph the patches where regrowth has been slow.

By Week 2, the shedding between your treatment cycles should be visibly different.

By Week 6, the regrowth in your existing patches should be coming in more consistently — and more fully — than before.

If at the end of 30 days you have not noticed a change in your regrowth environment — a reduction in between-cycle shedding, or new growth filling in more consistently in areas that have historically been slow —

Email us and every dollar comes back.

No forms. No phone calls with retention teams. No store credit. No questions.

Your refund processes within 48 hours.

This is an unconditional guarantee.

Why am I comfortable making this offer?

Because in two years and over 8,400 Australian customers, our return rate is under 3%.

More than 97 in 100 women who add HaloGrow™ to their alopecia protocol see enough in 30 days to keep going.

When you address the structural follicle environment that your primary treatment was never designed to reach — with actives at clinically meaningful concentrations — results are not a gamble. They are close to inevitable.

That's what a sub-3% return rate looks like.

Here's What to Do Next

Step 1: Click "CLAIM 70% OFF HALOGROW™ NOW" below — it takes you directly to our official secure website.

Step 2: Choose your supply. Most women in alopecia management start with the 3-month supply — significant regrowth improvement is typically visible at the 6–8 week mark, and having an uninterrupted supply through that window matters.

Step 3: Enter your shipping details. Orders placed before 2 PM AEST ship same day.

Step 4: Your bottle arrives in 3–5 business days.

Step 5: Part your hair to expose the thinning or patchy areas. Spray directly onto the scalp. Massage gently for 1–2 minutes. Leave in or rinse after 30 minutes. That is the entire protocol.

Step 6: Start your countdown.

Week 2: Reduced shedding between treatment cycles.

Week 4: Shower drain noticeably clearer. First signs of new growth in dormant patches.

Week 6: Visible improvement in regrowth consistency in areas that have been historically slow.

Week 12: Follicle environment your primary treatment was always trying to work with — and never had.

A note on ordering multiple bottles:

Many women in alopecia management order two or three to begin with. One reason is practical — you don't want to run out mid-cycle and interrupt the daily application protocol. The second reason is that they're sharing it with someone else in their support group who's been asking. The more bottles in an order, the more we save on fulfilment, and those savings come back to you in the price per bottle.

But whatever you order — don't leave this page intending to come back later.

Later = the discount is gone.

Later = we may be out of stock.

Later = another month of primary treatment working against a follicle environment that's still hardening.

Your follicles are not dead.

They are waiting for the structural environment to be restored.

Click below. Let's give it to them.

Remember, There's ZERO Risk

The only thing you risk right now is continuing without addressing the one mechanism your primary treatment was never designed to reach.

I've been a clinical dermatologist specialising in women's hair loss for fifteen years.

I've treated hundreds of women with alopecia areata, diffuse alopecia, and androgenetic alopecia presenting alongside autoimmune components.

Here is what I know: the women who get their hair back are not always the ones with the most aggressive treatment protocols.

They're the women who understood that primary treatment and follicle-environment support are two different things — and that both matter.

The alopecia community is one of the most research-literate, medically informed, self-advocating patient communities I have ever worked with.

You know what DHT is. You know what the anagen phase is. You know what perifollicular fibrosis is — now.

You know more than most GPs will ever tell you.

Don't let that knowledge sit unused while the structural clock keeps ticking.

HaloGrow™ is the follicle-support protocol this community has been missing.

The one that addresses what your treatment never could.

With a 30-day money-back guarantee that means you pay nothing if you don't see it working.

And over 8,400 women who've already added it to their protocol and felt the difference.

This Isn't About a Product. It's About Getting the Regrowth You Were Promised.

This is about the patches that keep cycling in and out — and finally staying.

This is about regrowth that comes in full, not thin. Present, not barely there.

This is about standing at your bathroom mirror with wet hair and seeing something you haven't seen in years.

This is about the photograph you've been avoiding. The morning you stop counting hairs in the drain. The first time someone reaches for your hair and you don't flinch.

You've done everything your dermatologist told you.

You've been your own researcher, your own advocate, your own case manager.

You deserve a protocol that addresses the full picture — not just the immune mechanism, but the structural environment your follicles need to actually come back.

HaloGrow™ is the missing piece.

The one aimed at the follicle itself.

Click below. Let's finish this.